Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?
Cameron DA, Anderson A, Toy E, Evans TR, Le Vay JH, Kennedy IC, Grieve RJ, Perren TJ, Jones A, Mansi J, Crown J, Leonard RC.
Cameron DA, et al. Among authors: kennedy ic.
Br J Cancer. 2002 Dec 2;87(12):1365-9. doi: 10.1038/sj.bjc.6600660.
Br J Cancer. 2002.
PMID: 12454763
Free PMC article.
Clinical Trial.